Among these 40 breast cancer patients, the level of HCK was higher in 6 triple-negative breast cancer patients than in 27 luminal type and 7 HER2 positive breast cancer patients (Fig. 2L). This evidence concerns the gene ERBB2 and breast carcinoma.